Patient Centric Success: Julie Powell on How Engagement Drives Better Therapies and Business Growth

Welcome to the latest of our Cognitant interview series, where we explore patient engagement and empowerment, with esteemed thought leaders and pioneers in healthcare.

We have the pleasure of introducing Julie Powell, the Corporate Development Director of Pleco Therapeutics, a biotech company dedicated to developing therapies for rare diseases. With +10 years of experience in the industry, Julie is renowned for her commitment to patient engagement and empowerment. Pleco Therapeutics has earned recognition for its patient-centric approach and dedication to advancing treatments for underserved populations.

Alex: Julie, I understand that you and Pleco Therapeutics are passionate about empowering patients and transforming lives through innovative therapies. What does empowering people in their health mean to you?

Julie: For me, empowering people in their health means we help them understand their health conditions, guiding them through their treatment options, and supporting them in making informed choices. When patients feel empowered, they’re not just passive recipients of care, they become active participants in their health journey.

Alex: What role do you think engagement with people around their health can play to support pharmaceutical companies’ business goals?

Julie: Engaging with patients is fundamental for pharmaceutical companies, not just from an ethical standpoint but also for business success. When we genuinely connect with patients and listen to their needs, we build trust and loyalty. This relationship means that patients are more likely to adhere to their prescribed treatments and share positive experiences with others.The insights we gain from these interactions can drive innovation and help us develop better, more targeted therapies that truly meet patients' needs.

Alex: What potential do you feel patient engagement can bring from the promotion of improved health outcomes?

Julie: Patient engagement can significantly boost health outcomes. When patients are engaged, they’re more likelly to follow their treatment plans, attend follow-up appointments, and maintain healthy habits. This level of involvement means treatments are more effective, and patients experience better overall health. Furthermore, engaged patients can offer critical feedback that helps us improve care delivery and develop therapies that are more closely aligned with real-world needs.

Alex: For you, what role do you think patient engagement can play in driving improvements to health services and health outcomes?

Julie: By actively involving patients in their care, we gain a deeper understanding of their needs and preferences. This insight allows healthcare professionals to tailor treatments more precisely, enhancing the effectiveness of care. When patients are engaged, they are more likely to voice their concerns and suggestions, leading to continuous improvement in healthcare services and ultimately better health outcomes.

Alex: If you had a magic wand, what change would you make to how patient engagement is carried out by the industry?

Julie: I’d establish mechanisms for ongoing patient feedback to continuously improve patient engagement strategies. With regular survey, focus groups and direct communication channels where patients can share their concerns, preferences and suggestions.

Alex: What top tip do you have for pharma professionals working in patient engagement?

Julie: My top tip for pharma professionals in patient engagement is to truly listen with empathy. It’s essential to understand the patient’s perspective and create a safe space for them to share their experiences and insights. Don’t just hear what they say—actively listen and be prepared to adapt your approach based on their feedback.